RecruitingNCT07633626
Vortioxetine and thinking changes during lung cancer treatment
About this title
Read the official source — NCT07633626Observational studyAges 18+ColombiaDepression
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- BogotáSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: March 10, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 24
- Sponsor
- Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Locations
- Colombia
- Age range
- Over 18 Years
- Official registry ID
- NCT07633626
- Official title
Show the full official title
Potential Effect of Vortioxetine on Cognitive Functioning of Patients With ALK-positive Non-Small Cell Lung Cancer Treated With Lorlatinib
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Bogotá
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
